Middle East and Africa Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class ; Route of Administration ; Application ; and Distribution Channel, and Country

Middle East and Africa Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class ; Route of Administration ; Application ; and Distribution Channel, and Country

  • November 2020 •
  • 140 pages •
  • Report ID: 5999722 •
  • Format: PDF
Market Introduction
Gastrointestinal drugs include promotility drugs, antimotility drugs, and drugs for acid-related disorders.The generally used gastrointestinal drugs as a group are considered safe.

Gastrointestinal (GI) disease affects the stomach, pancreas, rectum and large intestine, esophagus, small intestine, gallbladder, and liver. The main symptoms of gastrointestinal disorders are indigestion, heartburn, constipation bloating, and so on.

Market Overview and Dynamics
The Middle East & Africa gastrointestinal drugs market is expected to reach US$ 2,573.94 million by 2027 from US$ 2,000.27 million in 2019. The market is anticipated to grow at a CAGR of 3.3% during 2019–2027. The rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the major factors expected to boost the growth of the gastrointestinal drugs market in Middle East & Africa. However, the market is likely to get impacted by the risk factor such as low awareness associated with gastrointestinal disorders in low-income economies during the forecast period.

Key Market Segments
In terms of drug class, the acid neutralizers segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.In terms of route of administration, oral segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.

In terms of application, the inflammatory ulcerative colitis segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019. In terms of distribution channel, the retail pharmacies segment accounted for the largest share of the Middle East & Africa gastrointestinal drugs market in 2019.

Major Sources and Companies Listed
Several major primary and secondary sources associated with the Middle East & Africa gastrointestinal drugs market report are the World Health Organization (WHO), Celiac Disease Foundation, International Foundation for Gastrointestinal Disorders, and others.

MIDDLE EAST & AFRICA GASTROINTESTINAL DRUGS MARKET SEGMENTATION

By Drug Class
• Acid Neutralizers
• Antidiarrheal and Laxatives
• Anti-Inflammatory Drugs
• Antiemetic and Antinauseants
• Biologics
• Others

By Route of Administration
• Oral
• Parenteral

By Application
• Inflammatory Ulcerative Colitis
• Crohn’s Disease
• Irritable Bowel Syndrome
• Gastroenteritis
• Celiac Disease
• Others

By Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Country
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East and Africa

Company Profiles
• Johnson and Johnson Services, Inc.
• GlaxoSmithKline plc
• Celltrion Healthcare Co.,Ltd.
• AstraZeneca
• Takeda Pharmaceutical Company Limited
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.